As shown by Lei et al. [22], NKX3.1 stabilizes the tumor suppressor p53, inhibits the activation of protein kinase B (PKB/AKT), and blocks prostate cancer initiation caused by the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) loss in xenografts. The gene discussed is TP53; the disease is prostate carcinoma.